Previously we have shown that
microRNA miR-382 can facilitate loss of renal epithelial characteristics in cultured cells. This study examined the in vivo role of miR-382 in the development of renal interstitial
fibrosis in a mouse model. Unilateral
ureteral obstruction was used to induce renal interstitial
fibrosis in mice. With 3 days of unilateral
ureteral obstruction, expression of miR-382 in the obstructed kidney was increased severalfold compared with
sham-operated controls. Intravenous delivery of
locked nucleic acid-modified anti-miR-382 blocked the increase in miR-382 expression and significantly reduced inner medullary
fibrosis. Expression of predicted miR-382 target
kallikrein 5, a
proteolytic enzyme capable of degrading several
extracellular matrix proteins, was reduced with unilateral
ureteral obstruction. Anti-miR-382 treatment prevented the reduction of
kallikrein 5 in the inner medulla. Furthermore, the protective effect of the anti-miR-382 treatment against
fibrosis was abolished by renal knockdown of
kallikrein 5. Targeting of
kallikrein 5 by miR-382 was confirmed by 3'-untranslated region
luciferase assay. These data support a completely novel mechanism in which miR-382 targets
kallikrein 5 and contributes to the development of renal inner medullary interstitial
fibrosis. The study provided the first demonstration of an in vivo functional role of miR-382 in any species and any organ system.